The committee that is responsible for assessing the quality, safety and efficacy of advanced therapy medicines, including medicines classified as gene therapy, somatic cell therapy or tissue-engineered products. Abbreviated as CAT.
More information can be found under 'Committee for Advanced Therapies (CAT)'.